Highlights

array(40) {
  [0]=>
  string(4) "9089"
  ["article_id"]=>
  string(4) "9089"
  [1]=>
  string(179) "NRx Pharmaceuticals, Inc. Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis"
  ["article_title"]=>
  string(179) "NRx Pharmaceuticals, Inc. Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis"
  [2]=>
  string(166) "RADNOR, Pa., Jan. 16, 2024. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical compan"
  ["short_description"]=>
  string(166) "RADNOR, Pa., Jan. 16, 2024. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical compan"
  [3]=>
  string(267) "RADNOR, Pa., Jan. 16, 2024. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it has received Qualified Infectious Disease Product (QIDP) and Fast Track..."
  ["description"]=>
  string(267) "RADNOR, Pa., Jan. 16, 2024. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it has received Qualified Infectious Disease Product (QIDP) and Fast Track..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(147) "https://www.drugs.com/clinical_trials/nrx-pharmaceuticals-inc-announces-fda-qualified-infectious-product-qidp-fast-track-designation-nrx-21277.html"
  ["blog_url"]=>
  string(147) "https://www.drugs.com/clinical_trials/nrx-pharmaceuticals-inc-announces-fda-qualified-infectious-product-qidp-fast-track-designation-nrx-21277.html"
  [15]=>
  string(19) "2024-01-16 12:01:32"
  ["add_date"]=>
  string(19) "2024-01-16 12:01:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:50"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

NRx Pharmaceuticals, Inc. Announces FDA Qualified Infectious Disease Product (QIDP) and Fa

RADNOR, Pa., Jan. 16, 2024. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company

array(40) {
  [0]=>
  string(4) "9215"
  ["article_id"]=>
  string(4) "9215"
  [1]=>
  string(45) "3 Strategies to Boost Workforce Mental Health"
  ["article_title"]=>
  string(45) "3 Strategies to Boost Workforce Mental Health"
  [2]=>
  string(150) "Are you bracing for “Blue Monday“? The third Monday in January has become notorious as the saddest day of the year. Its dubious reputation"
  ["short_description"]=>
  string(150) "Are you bracing for “Blue Monday“? The third Monday in January has become notorious as the saddest day of the year. Its dubious reputation"
  [3]=>
  string(627) "

Are you bracing for “Blue Monday“? The third Monday in January has become notorious as the saddest day of the year. Its dubious reputation stems from a perfect storm of seasonal factors that conspire against us — dreary winter days, post-holiday debt, and failed New Year’s resolutions. But debilitating sadness often lasts more than a […]

&#nl

The post 3 Strategies to Boost Workforce Mental Health appeared first on TalentCulture.

&#nl" ["description"]=> string(627) "

Are you bracing for “Blue Monday“? The third Monday in January has become notorious as the saddest day of the year. Its dubious reputation stems from a perfect storm of seasonal factors that conspire against us — dreary winter days, post-holiday debt, and failed New Year’s resolutions. But debilitating sadness often lasts more than a […]

&#nl

The post 3 Strategies to Boost Workforce Mental Health appeared first on TalentCulture.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "4" ["category"]=> string(1) "4" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "55" ["rss_id"]=> string(2) "55" [14]=> string(166) "https://talentculture.com/blog/3-strategies-to-boost-workforce-mental-health/?utm_source=rss&utm_medium=rss&utm_campaign=3-strategies-to-boost-workforce-mental-health" ["blog_url"]=> string(166) "https://talentculture.com/blog/3-strategies-to-boost-workforce-mental-health/?utm_source=rss&utm_medium=rss&utm_campaign=3-strategies-to-boost-workforce-mental-health" [15]=> string(19) "2024-01-15 23:00:48" ["add_date"]=> string(19) "2024-01-15 23:00:48" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2024-01-23 20:20:52" ["create_at"]=> string(19) "2024-01-23 20:20:52" [19]=> string(0) "" ["slug"]=> string(0) "" }

3 Strategies to Boost Workforce Mental Health

Are you bracing for “Blue Monday“? The third Monday in January has become notorious as the saddest day of

array(40) {
  [0]=>
  string(4) "9209"
  ["article_id"]=>
  string(4) "9209"
  [1]=>
  string(66) "Cormica Bradford expanding equipment range to update capabilities "
  ["article_title"]=>
  string(66) "Cormica Bradford expanding equipment range to update capabilities "
  [2]=>
  string(124) "Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities."
  ["short_description"]=>
  string(124) "Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities."
  [3]=>
  string(124) "Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities."
  ["description"]=>
  string(124) "Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(173) "https://www.outsourcing-pharma.com/Article/2024/01/15/Cormica-Bradford-equipment-expansion-supporting-key-client-programs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(173) "https://www.outsourcing-pharma.com/Article/2024/01/15/Cormica-Bradford-equipment-expansion-supporting-key-client-programs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-15 22:23:00"
  ["add_date"]=>
  string(19) "2024-01-15 22:23:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:49"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Cormica Bradford expanding equipment range to update capabilities

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilit

array(40) {
  [0]=>
  string(4) "9309"
  ["article_id"]=>
  string(4) "9309"
  [1]=>
  string(72) "Carmot acquisition propels Roche to forefront of obesity drug leadership"
  ["article_title"]=>
  string(72) "Carmot acquisition propels Roche to forefront of obesity drug leadership"
  [2]=>
  string(145) "In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion."
  ["short_description"]=>
  string(145) "In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion."
  [3]=>
  string(145) "In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion."
  ["description"]=>
  string(145) "In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(178) "https://www.biopharma-reporter.com/Article/2024/01/15/carmot-acquisition-propels-roche-to-forefront-of-obesity-drug-leadership?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(178) "https://www.biopharma-reporter.com/Article/2024/01/15/carmot-acquisition-propels-roche-to-forefront-of-obesity-drug-leadership?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-15 21:20:00"
  ["add_date"]=>
  string(19) "2024-01-15 21:20:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:21:36"
  ["create_at"]=>
  string(19) "2024-01-23 20:21:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Carmot acquisition propels Roche to forefront of obesity drug leadership

In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a

array(40) {
  [0]=>
  string(4) "9307"
  ["article_id"]=>
  string(4) "9307"
  [1]=>
  string(86) "CellVoyant secures £7.6 million seed funding to develop stem cell therapies with AI"
  ["article_title"]=>
  string(86) "CellVoyant secures £7.6 million seed funding to develop stem cell therapies with AI"
  [2]=>
  string(153) "CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell therapies, has announced a Â"
  ["short_description"]=>
  string(153) "CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell therapies, has announced a Â"
  [3]=>
  string(176) "CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell therapies, has announced a Â7.6 million seed round."
  ["description"]=>
  string(176) "CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell therapies, has announced a Â7.6 million seed round."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(188) "https://www.biopharma-reporter.com/Article/2024/01/15/cellvoyant-secures-7.6-million-seed-funding-to-develop-stem-cell-therapies-with-ai?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(188) "https://www.biopharma-reporter.com/Article/2024/01/15/cellvoyant-secures-7.6-million-seed-funding-to-develop-stem-cell-therapies-with-ai?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-15 21:19:00"
  ["add_date"]=>
  string(19) "2024-01-15 21:19:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:21:36"
  ["create_at"]=>
  string(19) "2024-01-23 20:21:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

CellVoyant secures £7.6 million seed funding to develop stem cell therapies with AI

CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell

array(40) {
  [0]=>
  string(4) "9308"
  ["article_id"]=>
  string(4) "9308"
  [1]=>
  string(87) "Futura Medical extends commercialization agreement for erectile dysfunction treatment  "
  ["article_title"]=>
  string(87) "Futura Medical extends commercialization agreement for erectile dysfunction treatment  "
  [2]=>
  string(150) "Sexual health pharmaceutical company Futura Medical has extended its exclusive licensing agreement with Cooper Consumer Health for the rights to comme"
  ["short_description"]=>
  string(150) "Sexual health pharmaceutical company Futura Medical has extended its exclusive licensing agreement with Cooper Consumer Health for the rights to comme"
  [3]=>
  string(213) "Sexual health pharmaceutical company Futura Medical has extended its exclusive licensing agreement with Cooper Consumer Health for the rights to commercialize its topical, gel-based erectile dysfunction treatment."
  ["description"]=>
  string(213) "Sexual health pharmaceutical company Futura Medical has extended its exclusive licensing agreement with Cooper Consumer Health for the rights to commercialize its topical, gel-based erectile dysfunction treatment."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(191) "https://www.biopharma-reporter.com/Article/2024/01/15/Futura-Medical-extends-commercialization-agreement-for-erectile-dysfunction-treatment?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(191) "https://www.biopharma-reporter.com/Article/2024/01/15/Futura-Medical-extends-commercialization-agreement-for-erectile-dysfunction-treatment?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-15 21:19:00"
  ["add_date"]=>
  string(19) "2024-01-15 21:19:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:21:36"
  ["create_at"]=>
  string(19) "2024-01-23 20:21:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Futura Medical extends commercialization agreement for erectile dysfunction treatment

Sexual health pharmaceutical company Futura Medical has extended its exclusive licensing agreement with Cooper Consumer

array(40) {
  [0]=>
  string(4) "9210"
  ["article_id"]=>
  string(4) "9210"
  [1]=>
  string(84) "SGD Pharma to grow significantly in 2024 with investments and package manufacturing "
  ["article_title"]=>
  string(84) "SGD Pharma to grow significantly in 2024 with investments and package manufacturing "
  [2]=>
  string(111) "SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging."
  ["short_description"]=>
  string(111) "SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging."
  [3]=>
  string(111) "SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging."
  ["description"]=>
  string(111) "SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(166) "https://www.outsourcing-pharma.com/Article/2024/01/15/SGD-Pharma-s-goal-to-become-market-leader-in-glass-packaging?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(166) "https://www.outsourcing-pharma.com/Article/2024/01/15/SGD-Pharma-s-goal-to-become-market-leader-in-glass-packaging?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-15 20:12:00"
  ["add_date"]=>
  string(19) "2024-01-15 20:12:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:49"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

SGD Pharma to grow significantly in 2024 with investments and package manufacturing

SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging.

array(40) {
  [0]=>
  string(4) "9190"
  ["article_id"]=>
  string(4) "9190"
  [1]=>
  string(62) "UK health and medical suppliers to thrive in 2024, report says"
  ["article_title"]=>
  string(62) "UK health and medical suppliers to thrive in 2024, report says"
  [2]=>
  string(130) "Suppliers of health, medical supplies and equipment are set to go from strength to strength in 2024, according to a new report."
  ["short_description"]=>
  string(130) "Suppliers of health, medical supplies and equipment are set to go from strength to strength in 2024, according to a new report."
  [3]=>
  string(130) "Suppliers of health, medical supplies and equipment are set to go from strength to strength in 2024, according to a new report."
  ["description"]=>
  string(130) "Suppliers of health, medical supplies and equipment are set to go from strength to strength in 2024, according to a new report."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(131) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/uk-health-and-medical-suppliers-thriving-in-2024-report-says/"
  ["blog_url"]=>
  string(131) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/uk-health-and-medical-suppliers-thriving-in-2024-report-says/"
  [15]=>
  string(19) "2024-01-15 18:53:06"
  ["add_date"]=>
  string(19) "2024-01-15 18:53:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:42"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

UK health and medical suppliers to thrive in 2024, report says

Suppliers of health, medical supplies and equipment are set to go from strength to strength in 2024, according to a n

array(40) {
  [0]=>
  string(4) "9090"
  ["article_id"]=>
  string(4) "9090"
  [1]=>
  string(100) "New Prostate Cancer Foundation-Funded Research To Speed Up Prostate Cancer Clinical Trials Worldwide"
  ["article_title"]=>
  string(100) "New Prostate Cancer Foundation-Funded Research To Speed Up Prostate Cancer Clinical Trials Worldwide"
  [2]=>
  string(150) "LOS ANGELES, Jan. 11, 2024. New analysis of data published by Susan Halabi, PhD, of Duke University could facilitate approval of new prostate cancer t"
  ["short_description"]=>
  string(150) "LOS ANGELES, Jan. 11, 2024. New analysis of data published by Susan Halabi, PhD, of Duke University could facilitate approval of new prostate cancer t"
  [3]=>
  string(252) "LOS ANGELES, Jan. 11, 2024. New analysis of data published by Susan Halabi, PhD, of Duke University could facilitate approval of new prostate cancer treatments almost two years earlier than the current standard.&#nlThe study published online January..."
  ["description"]=>
  string(252) "LOS ANGELES, Jan. 11, 2024. New analysis of data published by Susan Halabi, PhD, of Duke University could facilitate approval of new prostate cancer treatments almost two years earlier than the current standard.&#nlThe study published online January..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(146) "https://www.drugs.com/clinical_trials/new-prostate-cancer-foundation-funded-research-speed-up-prostate-cancer-clinical-trials-worldwide-21268.html"
  ["blog_url"]=>
  string(146) "https://www.drugs.com/clinical_trials/new-prostate-cancer-foundation-funded-research-speed-up-prostate-cancer-clinical-trials-worldwide-21268.html"
  [15]=>
  string(19) "2024-01-14 12:01:56"
  ["add_date"]=>
  string(19) "2024-01-14 12:01:56"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:50"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

New Prostate Cancer Foundation-Funded Research To Speed Up Prostate Cancer Clinical Trials

LOS ANGELES, Jan. 11, 2024. New analysis of data published by Susan Halabi, PhD, of Duke University could facilitate app

array(40) {
  [0]=>
  string(4) "9231"
  ["article_id"]=>
  string(4) "9231"
  [1]=>
  string(90) "Growing AI adoption for fall prediction in Singapore and other AI integrations across APAC"
  ["article_title"]=>
  string(90) "Growing AI adoption for fall prediction in Singapore and other AI integrations across APAC"
  [2]=>
  string(145) "Also, Konkuk University Hospital is joining the latest R&D initiative in South Korea to further enhance Alzheimer's diagnosis through AI.&#nl"
  ["short_description"]=>
  string(145) "Also, Konkuk University Hospital is joining the latest R&D initiative in South Korea to further enhance Alzheimer's diagnosis through AI.&#nl"
  [3]=>
  string(145) "Also, Konkuk University Hospital is joining the latest R&D initiative in South Korea to further enhance Alzheimer's diagnosis through AI.&#nl"
  ["description"]=>
  string(145) "Also, Konkuk University Hospital is joining the latest R&D initiative in South Korea to further enhance Alzheimer's diagnosis through AI.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(126) "https://www.healthcareitnews.com/news/asia/growing-ai-adoption-fall-prediction-singapore-and-other-ai-integrations-across-apac"
  ["blog_url"]=>
  string(126) "https://www.healthcareitnews.com/news/asia/growing-ai-adoption-fall-prediction-singapore-and-other-ai-integrations-across-apac"
  [15]=>
  string(19) "2024-01-13 14:58:43"
  ["add_date"]=>
  string(19) "2024-01-13 14:58:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Growing AI adoption for fall prediction in Singapore and other AI integrations across APAC

Also, Konkuk University Hospital is joining the latest R&D initiative in South Korea to further enhance Alzheimer's

array(40) {
  [0]=>
  string(4) "9126"
  ["article_id"]=>
  string(4) "9126"
  [1]=>
  string(52) "Quick Notes: Device Approvals — Jan. 12, 2024"
  ["article_title"]=>
  string(52) "Quick Notes: Device Approvals — Jan. 12, 2024"
  [2]=>
  string(153) "&#nl        This edition of Quick Notes includes coverage of a cloth vest/halter that continuously monitors blood pressure, a Mayo Clinic deal on a newly"
  ["short_description"]=>
  string(153) "&#nl        This edition of Quick Notes includes coverage of a cloth vest/halter that continuously monitors blood pressure, a Mayo Clinic deal on a newly"
  [3]=>
  string(320) "&#nl        This edition of Quick Notes includes coverage of a cloth vest/halter that continuously monitors blood pressure, a Mayo Clinic deal on a newly cleared breast tumor 3D modeling device, and Medtronic clearances for a deep brain stimulation system for movement disorders and an insulin delivery system.&#nl      "
  ["description"]=>
  string(320) "&#nl        This edition of Quick Notes includes coverage of a cloth vest/halter that continuously monitors blood pressure, a Mayo Clinic deal on a newly cleared breast tumor 3D modeling device, and Medtronic clearances for a deep brain stimulation system for movement disorders and an insulin delivery system.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(80) "https://www.fdanews.com/articles/213118-quick-notes-device-approvals-jan-12-2024"
  ["blog_url"]=>
  string(80) "https://www.fdanews.com/articles/213118-quick-notes-device-approvals-jan-12-2024"
  [15]=>
  string(19) "2024-01-13 05:10:50"
  ["add_date"]=>
  string(19) "2024-01-13 05:10:50"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Quick Notes: Device Approvals — Jan. 12, 2024

&#nl This edition of Quick Notes includes coverage of a cloth vest/halter that continuously monitors blood pressu

array(40) {
  [0]=>
  string(4) "9127"
  ["article_id"]=>
  string(4) "9127"
  [1]=>
  string(81) "FDA Labels Recalls of ResMed Masks, Busse Sterile Trays, Fresenius Infusion Pumps"
  ["article_title"]=>
  string(81) "FDA Labels Recalls of ResMed Masks, Busse Sterile Trays, Fresenius Infusion Pumps"
  [2]=>
  string(153) "&#nl        The FDA has classified three recalls as Class I because use of the devices carries the potential of serious adverse health effects and death."
  ["short_description"]=>
  string(153) "&#nl        The FDA has classified three recalls as Class I because use of the devices carries the potential of serious adverse health effects and death."
  [3]=>
  string(163) "&#nl        The FDA has classified three recalls as Class I because use of the devices carries the potential of serious adverse health effects and death.&#nl      "
  ["description"]=>
  string(163) "&#nl        The FDA has classified three recalls as Class I because use of the devices carries the potential of serious adverse health effects and death.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(119) "https://www.fdanews.com/articles/213115-fda-labels-recalls-of-resmed-masks-busse-sterile-trays-fresenius-infusion-pumps"
  ["blog_url"]=>
  string(119) "https://www.fdanews.com/articles/213115-fda-labels-recalls-of-resmed-masks-busse-sterile-trays-fresenius-infusion-pumps"
  [15]=>
  string(19) "2024-01-13 05:00:41"
  ["add_date"]=>
  string(19) "2024-01-13 05:00:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

FDA Labels Recalls of ResMed Masks, Busse Sterile Trays, Fresenius Infusion Pumps

&#nl The FDA has classified three recalls as Class I because use of the devices carries the potential of serious